zenocutuzumab
evaluate pharma,elevation oncology,merus
['zenocutuzumab', 'elevation oncology', 'evaluate pharma']
response rates with zenocutuzumab hold up, but elevation oncology s rival project looks similar. 
Evaluate is the trusted provider of commercial intelligence including product sales and consensus forecasts to 2026 for the global life science industry.